We have received your feedback.Thank you for taking your time in view of your busy schedule.

Weekly News | Amount |
---|---|
Total
|
${lastRankDetail.pages.length} |
Financing | ${lastRankDetail.financing_pages.length} |
Product | ${lastRankDetail.product_pages.length} |
Negative | ${lastRankDetail.sentiment_pages.length} |
DingKeYiLiao is a high-tech company specializing in the research and development and production of vascular interventional medical treatment products, and has completed several registration tests and animal experiments of three types of products, among which DingKeYiLiao has the pre-market clinical trial of coronary drug balloon DCB ( Drug Coated Balloon ) Dissove TM with independent PCT intellectual property rights
Transactions
Research
Competition
Transactions
Funding
3 Fundings
Date | Amount | Round | Relative News |
---|---|---|---|
Oct 2017 | 20 million CNY | Series A | DingKeYiLiao received 20 million financing from Round A of Yuanhe Origin, and engaged in the research and development of vascular interventional medical treatment products |
Oct 2018 | 60 million CNY | Series B | News | DingKeYiLiao announced the completion of RMB 60 million Series B financing, and Qiming Venture Capital led the investment |
Aug 2020 | Nearly 100 million CNY | Series B+ | Involved in the balloon company "DingKeYiLiao" to complete nearly 100 million B+ round financing, Jinbang Capital and Huachuang Capital jointly led the investment |
Signals
Events
${currentEventsPage.count} Events
Events (${currentEventsPage.count}) | Date |
---|---|
Nothing Happens :-( | |
${e.desp} | ${e.date} |
News
${ rankDetail.pages.length } News Articles
${currentTimeRange.start} ~ ${currentTimeRange.end}
Article (${rankDetail.pages.length}) | Tag |
---|---|
${article.en_title} | ${article.tag} |
Industry Financing Info
Research
Intelligence
0 Research Briefs
Competition
Competitors
5 Competitors